Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Published on by Academic Awards

Assoc. Prof. Dr. Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Shanghai Jiao Tong University | China

Assoc. Prof. Dr. Qian Zhang is an accomplished nanomedicine researcher based at Shanghai Jiao Tong University, specializing in the synthesis, surface modification, and biomedical applications of colloidal and magnetic nanomaterials. She earned her Doctor of Science from Philipps-Universität Marburg under Prof. Wolfgang Parak and holds Master’s and Bachelor’s degrees from Sichuan Agriculture University and Qingdao Agriculture University, respectively. Assoc. Prof. Dr. Qian Zhang’s career trajectory includes postdoctoral research, assistant and associate researcher roles at SJTU, and a visiting scientist position at the Weizmann Institute of Science in Israel. Her research focuses on the design of drug delivery systems integrating diagnosis and treatment, interaction of nanomaterials with cancer cells, and physico-chemical characterization of metal-doped magnetic nanomaterials for MRI applications. She has successfully led multiple national and Shanghai-based research projects, including studies on ferromanganese-based nanocarriers for ferroptosis induction and immunotherapy, heat-induced hybrid iron oxide nanocarriers combined with siRNA for early cancer diagnosis, and urine exosomal drug delivery systems for prostate cancer treatment. Assoc. Prof. Dr. Qian Zhang has authored two influential books and 68 publications in high-impact journals, accruing 4,842 citations with an h-index of 29, reflecting her strong scientific influence. Her work demonstrates remarkable innovation, translational relevance, and international collaboration, establishing her as a leading figure in nanomedicine and targeted cancer therapy.

Profile: Scopus

Featured Publications

Zhang, Q. (2026). Element-doped ferrite nanoparticles: From magnetic property tuning to biomedical applications. Coordination Chemistry Reviews, 548, 217151.

Zhao, Y., Zhang, Q., Zhang, A., Pan, S., Cheng, J., Ning, J., … Wang, C. (2025). A novel near-infrared AP-M@AntiACLY detection probe based on SERS to trace detection of serum ACLY for early diagnosis of pediatric sepsis. Sensors and Actuators B: Chemical.

Jin, Y., Huang, J., Tang, Y., Li, Z., Zhang, A., Yang, Z., … Zhang, Q. (2024). Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer. Chemical Engineering Journal, 497.

[Author(s) not fully listed]. (2024). Flower-shaped magnetic fluorescent nanoparticles based lateral flow biosensor for highly sensitive detection of cardiac troponin I. Sensors and Actuators B: Chemical.

[Author(s) not fully listed]. (2024). An ingestible near-infrared fluorescence capsule endoscopy for specific gastrointestinal diagnoses. Biosensors and Bioelectronics.

 

Erick Ondari | Bio Nanotechnology | Best Researcher Award

Published on by Academic Awards

Dr. Erick Ondari | Bio Nanotechnology | Best Researcher Award

Dr. Erick Ondari, Kisii University, Kenya

Dr. Erick Nyakundi Ondari, Ph.D., is a distinguished Kenyan researcher and Senior Lecturer at Kisii University, serving as Head of the Department of Biological Sciences. With a strong academic foundation in Biotechnology from Karpagam University, India, Dr. Ondari has cultivated interdisciplinary expertise in nanotechnology, bioinformatics, molecular biology, and natural product research. He has actively contributed to scientific knowledge through impactful publications, global conference presentations, and collaborative research projects, including co-PI roles in multimillion-shilling grants on cervical cancer screening and COVID-19 vaccine development. His work in mechanistic nanoparticle research and phytochemical therapeutics has earned him multiple international honors, including awards from conferences in Thailand, India, and Uganda. Dr. Ondari’s mentoring excellence is evident through his students’ success in securing prestigious fellowships and travel grants. A peer reviewer for top-tier journals, he also contributes to curriculum development and policy advisory roles in Kenyan and East African institutions. Committed to public health outreach, he has led sensitization programs on HIV/AIDS and substance abuse. His technical skills range from flow cytometry to nanomaterial synthesis, backed by certifications in good clinical and laboratory practices, ethics, and bioinformatics. Dr. Ondari is a dynamic force in African STEM advancement, combining research innovation, leadership, and community service with exceptional professionalism.

Publication Profile

Orcid

Google Scholar

🎓 Educational Background

Dr. Erick Ondari has pursued a comprehensive and interdisciplinary academic journey in the life sciences, particularly in the fields of biotechnology and bioinformatics. He earned his Ph.D. in Biotechnology from Karpagam University, India (2012–2016), focusing on the mechanistic characterization of Tridax procumbens-mediated silver nanoparticles as novel nanocides against Anopheles stephensi. Prior to this, he completed his Master of Science in Biotechnology at AVS College of Arts & Sciences, Periyar University (2009–2011), where his thesis involved amplification of the emm gene to confirm drug resistance in Streptococcus pyogenes in the Salem District. His academic foundation began with a Bachelor’s degree in Biotechnology (2006–2009) from KSR College of Arts & Sciences, where he researched the isolation and characterization of Actinomycetes with antibiotic properties. Additionally, Dr. Ondari pursued two postgraduate diplomas at Bharathiar University: one in Chemi-informatics (2011–2012), focused on molecular modeling and docking of the DAP gene from Streptococcus suis and S. parauberis, and another in Bioinformatics (2010–2011), centered on annotating non-coding regions of Streptococci species. His foundational education includes a KCSE from Sameta Boys High School (2005) and KCPE from Sironga D.E.B Primary School (2001), marking the beginning of a distinguished academic and research career.

📘 Professional and Work Experience

Dr. Erick Nyakundi Ondari has amassed a diverse and impactful professional background in academia and research across East Africa and India. Currently, he serves as a Senior Lecturer and Head of the Department of Biological Sciences at Kisii University’s School of Pure and Applied Sciences, a position he has held since June 2023. He has been a Lecturer at Kisii University since September 2017, contributing to both undergraduate and postgraduate teaching and research. From 2018 to 2022, Dr. Ondari was a Visiting Lecturer at Kampala International University – Western Campus, Uganda, where he also served as Head of the Biochemistry Department (2020–2021) and Postgraduate Coordinator (2022). Prior to this, he worked as a Full-Time Lecturer at Kampala International University in Dar-es-Salaam, Tanzania (2017–2018). His earlier teaching roles include Part-Time Lecturer positions at JKUAT-Kisii Campus, Kisii University, and Africa Nazarene University. Dr. Ondari’s research journey began in India, where he was a Research Scholar at Karpagam University (2012–2015) and a Research Assistant under the University Grants Commission at Bharathiar University (2011–2012). This extensive cross-border academic experience underscores his commitment to education, research, and capacity building in molecular sciences and biotechnology across the region.

🏅 Honors, Grants, and Consultancies

Dr. Erick Ondari has been consistently recognized for his outstanding contributions to biotechnology and health sciences through numerous honors, grants, and consultancies. Notably, he secured an AGNES-Alexander Humboldt Stiftung Travel Grant for his student in 2024 and served as a Guest Speaker at the 2023 International Conference on Trends in Biological Sciences in India, where he presented on “Nanotechnology in Health.” He actively participated in the AfriLSc RNA Salon Symposium and presented groundbreaking research on schistosomiasis diagnostics at an international nursing conference. In 2023, Dr. Ondari received the Best Poster Presentation Award at the Uganda Virus Research Institute symposium. His students have also flourished under his mentorship, winning travel grants to prestigious events like the IBRO World Congress of Neuroscience in Spain. In 2022, he guided a Ph.D. student awarded a DBT-UNESCO-TWAS fellowship for tuberculosis research. As Co-Principal Investigator, he secured a KShs 50 million grant for cervical cancer screening innovations in Kenya and was instrumental in obtaining a multi-million Ugandan Shillings grant for COVID-19 vaccine development with Makerere University. Dr. Ondari also participated in the H3ABioNet IBT Course for bioinformatics, showcasing his commitment to capacity-building and translational research across Africa

🔬 Research Focus

Dr. Erick Ondari’s research is firmly rooted in interdisciplinary biosciences, with a strong emphasis on biotechnology, nanotechnology, bioinformatics, and natural product research. His work predominantly addresses vector control and antimicrobial resistance through the innovative application of green nanotechnology, as demonstrated in his highly cited paper on the optimization of silver nanoparticles for targeting Anopheles stephensi, a malaria vector. His research integrates molecular physiology and nanobiotechnology, focusing on the synthesis, characterization, and biological evaluation of biogenic nanoparticles for mosquitocidal and antimicrobial activity. Dr. Ondari’s contributions to computational biology are evident through molecular modeling and docking studies aimed at understanding protein-ligand interactions in pathogens like Streptococcus suis, Streptococcus parauberis, and Pneumocystis jiroveci. His bioinformatics work on annotating non-coding genomic regions and studying antimicrobial agents from natural phytochemicals underscores his commitment to addressing pressing public health challenges using eco-friendly and precision-based scientific methods. His multidisciplinary expertise positions him within the emerging fields of environmental nanoscience, phytochemical drug discovery, and computational toxicology, making significant impacts on both human health and environmental safety. Dr. Ondari’s research profile aligns well with modern global scientific priorities, especially in neglected tropical diseases, biomedical innovation, and bio-nano interface technologies.

Publication Top Notes

📄 Green chemistry focus on optimization of silver nanoparticles… – Cited by 56 (2015) 🧪🦟
📄 Antimicrobial activity of biogenic silver nanoparticles synthesized using Tridax procumbens L – Cited by 25 (2014) 🌿🧬
📄 Effect of biopolymer stabilized silver nanoparticles on antioxidant genes… – Cited by 6 (2017) 🧫🧠
📄 Annotation of non-coding regions of streptococci family: A case study – Cited by 2 (2013) 🧬🧠
📄 Larvicidal and pupicidal effect of Tridax procumbens mediated synthesis of silver nanoparticles… – Cited by 1 (2014) 🦟🌱
📄 Synthetic Biology Industrial Revolution, Social And Ethical Concerns – Not cited (2019) ⚙️🌍
📄 Molecular modeling and docking studies of dihydrodipicolinate reductase enzyme… – Not cited (2014) 💻🧪
📄 Secondary metabolites from Annona squamosa as a potential antimicrobial agent – Not cited (2014) 🍃🧫
📄 Molecular modeling approach and RMSD calibration for superimposed 3D structure… – Not cited (2014) 🧠🖥️

Huapan Fang | Biomaterials | Best Researcher Award

Published on by Academic Awards

Prof. Huapan Fang | Biomaterials | Best Researcher Award

Prof. Huapan Fang, Xiamen University, China

Prof. Huapan Fang is an Associate Professor and Doctoral Supervisor at the College of Chemistry and Chemical Engineering, Xiamen University. He specializes in polymer chemistry, nanomedicine, and biomedical materials. With a Ph.D. from the University of Science and Technology of China, he has held research roles at the Chinese Academy of Sciences, Suzhou University, and Xiamen University. Prof. Fang has published extensively in Nature Communications, ACS Nano, JACS, and more, contributing significantly to gene delivery, immunotherapy, and biomaterials. He is recognized for his innovative research and is a recipient of multiple high-level talent honors. 🧪📚🇨🇳

Publication Profile

Scopus

🎓 Education

Prof. Fang earned his Ph.D. in Polymer Chemistry and Physics from the University of Science and Technology of China (2014–2019), where he conducted pioneering research in gene transfection materials and polymeric drug delivery. Prior to that, he completed his Bachelor’s degree in Polymer Materials and Engineering at Hubei University (2010–2014), building a strong foundation in synthetic and applied polymer science. His academic journey reflects a continuous trajectory in high-level interdisciplinary training, blending polymer chemistry with biomedical applications. This rigorous education positioned him at the forefront of next-generation polymeric biomaterials and nanotherapeutics. 📘🎓🔬

💼 Experience

Since January 2023, Prof. Fang has been serving as Associate Professor and Doctoral Supervisor at Xiamen University, also holding the title of Nanqiang Young Top Talent. From 2020 to 2022, he was a postdoctoral researcher at the Institute of Functional Nano & Soft Materials, Soochow University. Before that, he worked at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, as an Assistant Researcher from late 2019 to mid-2020. His professional experience spans leading Chinese institutions and research labs, focusing on cutting-edge topics in nanomedicine, polymers, and biomaterial-based drug delivery. 🧑‍🔬🏫🧫

🏅 Awards & Honors

Prof. Huapan Fang has been honored with the Chinese Academy of Sciences President’s Excellence Award in 2019, recognizing his outstanding Ph.D. research contributions. He was named a High-Level Talent in Fujian Province (2023) and in Xiamen City (2024), highlighting his scientific leadership and innovation. As a Nanqiang Young Top Talent at Xiamen University, he is acknowledged as a rising figure in polymer and nanomedical research. These accolades underscore his influential contributions to biomedical polymer science and the application of smart materials in cancer therapy and drug delivery. 🏆🌟🇨🇳

🔬 Research Focus

Prof. Fang’s research centers on biomedical polymers, nanomedicine, and gene delivery systems. His work involves developing innovative polymeric materials for disease treatment, including cancer immunotherapy, mRNA vaccines, and pulmonary disease therapeutics. He explores the tumor microenvironment, polymer degradation, epigenetic regulation, and synergistic drug delivery approaches. His team combines polymer chemistry with biology to design responsive, targeted, and low-toxicity nanocarriers for effective clinical translation. His most cited works demonstrate breakthroughs in oral drug delivery, intraperitoneal chemotherapy, and inhalable siRNA nanoplatforms for fibrosis and cancer. 🧬🩺🧫💊

Publication Top Notes

  • 🧬 Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo, Nat. Commun., 2021, cited by many in cancer immunotherapy research. 🧫🛡️

  • 🧪 Molecular strings significantly improved the gene transfection efficiency of polycations, J. Am. Chem. Soc., 2018, widely cited in gene delivery systems. 🧬📈

  • 💊 In situ polymerization of zwitterions on therapeutic proteins to enable their effective oral delivery, ACS Nano, 2023, enhancing protein drug delivery research. 🌐🧪

  • 🧫 Regulating the obesity-related tumor microenvironment to improve cancer immunotherapy, ACS Nano, 2023, linking obesity & tumor immunology. 🍔🧬

  • 🧬 Cancer cell membrane-enveloped dexamethasone normalizes the tumor microenvironment and enhances gynecologic cancer chemotherapy, ACS Nano, 2023, key in tumor microenvironment modulation. 🧫💊

  • 🌬️ Inhalable siRNA targeting IL-11 nanoparticles significantly inhibit bleomycin-induced pulmonary fibrosis, ACS Nano, 2025, novel for pulmonary fibrosis. 🫁🧬

  • 💉 mRNA vaccines contribute to innate and adaptive immunity to enhance immune response In Vivo, Biomaterials, 2024, supports next-gen vaccine research. 💊🦠

  • 🔥 Carrier-free multifunctional nanomedicine for enhanced hyperthermic intraperitoneal chemotherapy, Chem. Eng. J., 2024, revolutionizing HIPEC therapy. 🌡️💥

  • 🧪 Latest advancements and trends in biomedical polymers for disease prevention, diagnosis, treatment, J. Controlled Release, 2025, comprehensive review in biomaterials. 🧬📊

  • 🧠 Metabolism of cancer cells and immune cells in cancer initiation, progression, and metastasis, Theranostics, 2025, cited for cancer metabolism insights. ⚙️🧬

 

Ziliang Zheng | Nanomedicine Award | Best Researcher Award

Published on by Academic Awards

Prof. Ziliang Zheng | Nanomedicine Award | Best Researcher Award

Prof. Ziliang Zheng, Laboratory of Molecular Imaging, Fifth Hospital of Shanxi Medical University (Shanxi Provincial People’s Hospital, China

Prof. Ziliang Zheng 🎓 is a leading figure in molecular imaging and nano biomedicine. With a Master’s Degree, he serves as Deputy Director of the Molecular Imaging Lab at Shanxi Provincial People’s Hospital. He’s a prolific researcher, with groundbreaking work in NIR-II fluorescence imaging, resulting in 38 SCI papers and 17 patents. Prof. Zheng’s innovative systems, like the NIR-II fluorescence imaging system, have advanced surgical navigation and intraoperative pathology. An esteemed educator, he mentors doctoral and master’s students, fostering future leaders in nanomedicine. His accolades include the Shanxi Provincial Science and Technology Cooperation Award (First Prize) and the Huaxia Medical Science and Technology Award (Second Prize).

Publication Profile

Google Scholar

Research Achievements 🏆

Ziliang Zheng, a distinguished professor and master’s degree supervisor, has made remarkable contributions in the field of molecular imaging at Shanxi Provincial People’s Hospital. His pioneering work focuses on near infrared two-region (NIR-II) fluorescence imaging technology, culminating in the development of advanced NIR-II fluorescence imaging systems for surgical navigation, intraoperative pathology analysis, and endoscopic diagnosis. With 38 SCI papers and 17 patents to his name, Zheng’s research has garnered international recognition. His dedication to scientific rigor and clinical translation has earned him prestigious awards, including the Shanxi Provincial Science and Technology Cooperation Award.

Honors & Recognition 🌟

Zheng’s contributions have been honored with awards such as the Huaxia Medical Science and Technology Award and the China Anti-Cancer Association Science and Technology Award. These accolades not only celebrate his scientific achievements but also validate his unwavering commitment to improving patient care through cutting-edge research and innovation.

 

Research Focus

Zheng Z. is a prolific researcher whose work primarily focuses on developing advanced nanotheranostic platforms for cancer diagnosis and treatment. 🧪 His research spans various areas, including the design and synthesis of multifunctional nanomaterials, such as silica-based nanotheranostics and zeolite-supported catalysts, for precise imaging (MRI/NIR-II fluorescence) and therapeutic interventions (photothermal therapy, gas therapy). 🩺 Zheng Z.’s innovative approaches aim to address key challenges in tumor diagnosis and therapy, paving the way for bench-to-bedside applications with potential clinical impact. 🚀

 

Publication Top Notes

 

Aniket Gade | Nanobiotechnology Award | Best Researcher Award

Published on by Academic Awards

Dr. Aniket Gade | Nanobiotechnology Award | Best Researcher Award

Dr. Aniket Gade, Institute of Chemical Technology, India

🌱 Dr. Aniketkumar K. Gade, an Associate Professor at the Institute of Chemical Technology, Mumbai, boasts a rich academic journey spanning over two decades. With a Ph.D. in Biotechnology, his expertise lies in bioinformatics and nanobiotechnology. Dr. Gade’s pioneering research focuses on mycofabrication of nanoparticles and their applications in antimicrobial therapies. Recognized globally, he has received prestigious awards and grants for his contributions. Beyond academia, he promotes research through mentorship and extensive outreach activities. Dr. Gade’s commitment to advancing biotechnology is evident in his numerous patents, product developments, and prolific publications. 🏅🔬

 

Publication Profile

Google Scholar

Educational Qualification

🎓 Dr. Aniketkumar K. Gade’s academic journey is marked by stellar achievements and a thirst for knowledge. He obtained his Ph.D. in Biotechnology in 2012, delving into the intriguing realm of mycofabrication of Silver Nanoparticles. Prior to this, he pursued an Advanced Diploma in Bioinformatics from Pune University in 2002, showcasing his early fascination with interdisciplinary sciences. His academic foundation was laid with a post-graduate degree in Biotechnology from Amravati University in 2000, following an undergraduate education in Microbiology, Chemistry, and Botany from the same alma mater. His academic pursuits culminated in a rewarding post-doctoral research stint at Utah State University in 2013-2014. 📚

Professional Experience

🎓 Dr. Aniketkumar K. Gade embarked on his professional journey as a full-time lecturer in Bioinformatics at Vidya Pratishthan’s Arts, Science, and Commerce College, Baramati, where he honed his teaching skills from July 2003 to December 2005. Transitioning to higher academia, he served as an Associate Professor at the Department of Biotechnology, Government Institute of Sciences, Aurangabad, briefly in 2019. However, his mainstay was at Sant Gadge Baba Amravati University, where he dedicated over seventeen years as an Assistant Professor until August 2022. His tenure there witnessed significant academic contributions and research advancements. 📚

 

Awards

🏆 Dr. Aniketkumar K. Gade’s accolades illuminate his remarkable academic journey. From securing the seventh merit during his graduation to qualifying the Graduate Aptitude Test in Engineering (GATE) in 2000, his journey has been marked by excellence. Noteworthy achievements include winning the INSA Summer Research Fellowship in 2008 and receiving the prestigious Young Scientist Award in 2012 at national and international conferences. His research contributions have been internationally recognized, earning him the International Award from Biotechnology Advances and inclusion in Stanford University’s list of top 2% most influential scientists. His recent accolades include the POLONEZ BIS Marie Skłodowska-Curie Fellowship from 2023 to 2025, highlighting his continued impact in the field. 🌟

 

Research Focus

🔬 Dr. Aniketkumar K. Gade’s research focus encompasses the synthesis and application of nanoparticles, particularly silver nanoparticles, in antimicrobial and therapeutic contexts. His work explores the potential of fungal-mediated synthesis, such as Fusarium and Phoma species, in producing nanoparticles with antimicrobial properties. Through innovative methodologies, he investigates the efficacy of these nanoparticles against multidrug-resistant bacteria, pathogenic fungi, and viruses. Dr. Gade’s contributions to myconanotechnology and green synthesis methodologies underscore his commitment to sustainable and biocompatible nanoparticle production. His interdisciplinary approach bridges biology, nanotechnology, and materials science, paving the way for novel therapeutic interventions and environmental solutions. 🔍🌱

 

Publication Top Notes

  1. “Silver nanoparticles as a new generation of antimicrobials” (2009) – cited by 7252 🌟
  2. “Silver nanoparticles: the powerful nanoweapon against multidrug‐resistant bacteria” (2012) – cited by 1666 💊
  3. “Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole” (2009) – cited by 1004 🍄
  4. “Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria” (2008) – cited by 720 🦠
  5. “Exploitation of Aspergillus niger for synthesis of silver nanoparticles” (2008) – cited by 644 🔬
  6. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus
  7. Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants
  8. Silver nanoparticles: therapeutical uses, toxicity, and safety issues
  9. Fusarium solani: a novel biological agent for the extracellular synthesis of silver nanoparticles
  10. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3